NEUE
NYSE:NEUE
NeueHealth, Inc.
- Stock
Last Close
5.17
25/09 13:46
Market Cap
41.95M
Beta: 0.85
Volume Today
6.14K
Avg: 23.42K
PE Ratio
−0.04
PFCF: −0.02
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|
average inventory | 513.67M - | 2.11B 310.26% | 2.01B 4.86% | |
average payables | 57.57M - | 38.30M 33.47% | 15.28M 60.11% | |
average receivables | 79.70M - | 108.82M 36.53% | 136.86M 25.77% | |
book value per share | 233.55 - | 91.50 60.82% | -43.19 147.20% | |
capex per share | -6.20 - | -3.49 43.76% | -0.36 89.56% | |
capex to depreciation | -0.86 - | -0.54 36.68% | -0.12 77.91% | |
capex to operating cash flow | -0.37 - | -0.12 68.41% | 0.00 100.91% | |
capex to revenue | -0.02 - | -0.04 81.78% | -0.00 93.17% | |
cash per share | 88.47 - | 27.69 68.70% | 11.76 57.52% | |
days of inventory on hand | 289.75 - | 1.75K 505.65% | 301.27 82.83% | |
days payables outstanding | 16.33 - | 10.30 36.89% | 4.34 57.91% | |
days sales outstanding | 23.85 - | 57.71 141.91% | 48.73 15.56% | |
debt to assets | 0.04 - | 0.07 51.26% | 0.30 363.83% | |
debt to equity | 0.14 - | 0.42 211.91% | -1.08 355.35% | |
dividend yield | ||||
earnings yield | -0.88 - | -3.56 305.14% | -17.55 393.23% | |
enterprise value | 1.22B - | 496.08M 59.17% | 348.67M 29.71% | |
enterprise value over ebitda | -3.96 - | -2.01 49.14% | -2.41 19.88% | |
ev to operating cash flow | 14.81 - | 2.12 85.71% | -0.13 106.04% | |
ev to sales | 0.80 - | 0.66 17.76% | 0.30 54.52% | |
free cash flow per share | 10.53 - | 26.31 149.79% | -343.15 1,404.20% | |
free cash flow yield | 0.04 - | 0.51 1,221.98% | -41.59 8,320.42% | |
graham net net | -265.80 - | -231.91 12.75% | -108.00 53.43% | |
graham number | 1.13K - | 617.14 45.24% | 375.07 39.23% | |
income quality | -0.07 - | -0.17 148.95% | 2.15 1,349.30% | |
intangibles to total assets | 0.32 - | 0.11 66.56% | 0.08 29.90% | |
interest coverage | -47.53 - | -28.76 39.49% | -15.10 47.48% | |
interest debt per share | 33.09 - | 40.26 21.68% | 51.36 27.58% | |
inventory turnover | 1.26 - | 0.21 83.49% | 1.21 482.49% | |
invested capital | 0.14 - | 0.42 211.91% | -1.08 355.35% | |
market cap | 1.35B - | 409.14M 69.68% | 65.62M 83.96% | |
net current asset value | -664.61M - | -154.73M 76.72% | -391.17M 152.80% | |
net debt to ebitda | 0.44 - | -0.35 180.65% | -1.96 455.31% | |
net income per share | -241.66 - | -185.00 23.45% | -144.76 21.75% | |
operating cash flow per share | 16.74 - | 29.80 78.06% | -342.79 1,250.30% | |
payables turnover | 22.36 - | 35.43 58.46% | 84.16 137.57% | |
receivables turnover | 15.30 - | 6.33 58.66% | 7.49 18.43% | |
research and ddevelopement to revenue | ||||
return on tangible assets | -0.49 - | -0.35 28.21% | -1.02 190.56% | |
revenue per share | 308.59 - | 95.47 69.06% | 145.94 52.86% | |
roe | -1.03 - | -2.02 95.40% | 3.35 265.79% | |
roic | -0.24 - | -0.35 49.43% | -11.69 3,193.73% | |
sales general and administrative to revenue | 0.26 - | 0.42 63.35% | 0.22 46.78% | |
shareholders equity per share | 233.55 - | 91.50 60.82% | -43.19 147.20% | |
stock based compensation to revenue | 0.05 - | 0.15 222.98% | 0.07 50.64% | |
tangible asset value | 105.54M - | 433.35M 310.60% | -347.86M 180.27% | |
tangible book value per share | 21.53 - | 55.08 155.87% | -43.73 179.40% | |
working capital | -623.35M - | -122.53M 80.34% | -302.33M 146.75% |
All numbers in USD (except ratios and percentages)